Reduced Global Efficiency and Random Network Features in Patients with Relapsing-Remitting Multiple Sclerosis with Cognitive Impairment

References

1. 1.↵
   1. Kipp M,
   2. van der Valk P,
   3. Amor S

   . Pathology of multiple sclerosis. CNS Neurol Disord Drug Targets 2012;11:506–17 doi:10.2174/187152712801661248 pmid:22583433

   CrossRefPubMed
2. 2.↵
   1. Sbardella E,
   2. Petsas N,
   3. Tona F, et al

   . Assessing the correlation between grey and white matter damage with motor and cognitive impairment in multiple sclerosis patients. PLoS One 2013;8:e63250 doi:10.1371/journal.pone.0063250 pmid:23696802

   CrossRefPubMed
3. 3.↵
   1. Geurts JJ,
   2. Barkhof F

   . Grey matter pathology in multiple sclerosis. Lancet Neurol 2008;7:841–51 doi:10.1016/S1474-4422(08)70191-1 pmid:18703006

   CrossRefPubMedWeb of Science
4. 4.↵
   1. Bo L,
   2. Geurts JJ,
   3. van der Valk P, et al

   . Lack of correlation between cortical demyelination and white matter pathologic changes in multiple sclerosis. Arch Neurol 2007;64:76–80 doi:10.1001/archneur.64.1.76 pmid:17210812

   CrossRefPubMedWeb of Science
5. 5.↵
   1. Tijms BM,
   2. Series P,
   3. Willshaw DJ, et al

   . Similarity-based extraction of individual networks from gray matter MRI scans. Cereb Cortex 2012;22:1530–41 doi:10.1093/cercor/bhr221 pmid:21878484

   CrossRefPubMedWeb of Science
6. 6.↵
   1. Tewarie P,
   2. Steenwijk MD,
   3. Tijms BM, et al

   . Disruption of structural and functional networks in long-standing multiple sclerosis. Hum Brain Mapp 2014;35:5946–61 doi:10.1002/hbm.22596 pmid:25053254

   CrossRefPubMed
7. 7.↵
   1. He Y,
   2. Chen ZJ,
   3. Evans AC

   . Small-world anatomical networks in the human brain revealed by cortical thickness from MRI. Cereb Cortex 2007;17:2407–19 doi:10.1093/cercor/bhl149 pmid:17204824

   CrossRefPubMedWeb of Science
8. 8.↵
   1. Watts DJ,
   2. Strogatz SH

   . Collective dynamics of ‘small-world’ networks. Nature 1998;393:440–42 doi:10.1038/30918 pmid:9623998

   CrossRefPubMedWeb of Science
9. 9.↵
   1. Van Essen DC

   . A tension-based theory of morphogenesis and compact wiring in the central nervous system. Nature 1997;385:313–18 doi:10.1038/385313a0 pmid:9002514

   CrossRefPubMedWeb of Science
10. 10.↵
    1. He Y,
    2. Chen Z,
    3. Gong G, et al

    . Neuronal networks in Alzheimer’s disease. Neuroscientist 2009;15:333–50 doi:10.1177/1073858409334423 pmid:19458383

    CrossRefPubMedWeb of Science
11. 11.↵
    1. Tijms BM,
    2. Sprooten E,
    3. Job D, et al

    . Grey matter networks in people at increased familial risk for schizophrenia. Schizophr Res 2015;168:1–8 doi:10.1016/j.schres.2015.08.025 pmid:26330380

    CrossRefPubMed
12. 12.↵
    1. van Duinkerken E,
    2. Ijzerman RG,
    3. Klein M, et al

    . Disrupted subject-specific gray matter network properties and cognitive dysfunction in type 1 diabetes patients with and without proliferative retinopathy. Hum Brain Mapp 2016;37:1194–208 doi:10.1002/hbm.23096 pmid:26700243

    CrossRefPubMed
13. 13.↵
    1. Rimkus CM,
    2. Schoonheim MM,
    3. Steenwijk MD, et al

    . Gray matter networks and cognitive impairment in multiple sclerosis. Mult Scler 2018;25:382–91 doi:10.1177/1352458517751650 pmid:29320933

    CrossRefPubMed
14. 14.↵
    1. Pagani E,
    2. Rocca MA,
    3. Gallo A, et al

    . Regional brain atrophy evolves differently in patients with multiple sclerosis according to clinical phenotype. AJNR Am J Neuroradiol 2005;26:341–46 pmid:15709132

    Abstract/FREE Full Text
15. 15.↵
    1. Fleischer V,
    2. Groger A,
    3. Koirala N, et al

    . Increased structural white and grey matter network connectivity compensates for functional decline in early multiple sclerosis. Mult Scler 2017;23:432–41 doi:10.1177/1352458516651503 pmid:27246143

    CrossRefPubMed
16. 16.↵
    1. Thompson AJ,
    2. Banwell BL,
    3. Barkhof F, et al

    . Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 2018;17:162–73 doi:10.1016/S1474-4422(17)30470-2 pmid:29275977

    CrossRefPubMed
17. 17.↵
    1. Walker LA,
    2. Marino D,
    3. Berard JA, et al

    . Canadian Normative Data for Minimal Assessment of Cognitive Function in Multiple Sclerosis. Can J Neurol Sci 2017;44:547–55 doi:10.1017/cjn.2017.199 pmid:28683843

    CrossRefPubMed
18. 18.↵
    1. Valverde S,
    2. Oliver A,
    3. Llado X

    . A white matter lesion-filling approach to improve brain tissue volume measurements. Neuroimage Clin 2014;6:86–92 doi:10.1016/j.nicl.2014.08.016 pmid:25379419

    CrossRefPubMed
19. 19.↵
    1. Rubinov M,
    2. Sporns O

    . Complex network measures of brain connectivity: uses and interpretations. Neuroimage 2010;52:1059–69 doi:10.1016/j.neuroimage.2009.10.003 pmid:19819337

    CrossRefPubMedWeb of Science
20. 20.↵
    1. Humphries MD,
    2. Gurney K

    . Network ‘small-world-ness’: a quantitative method for determining canonical network equivalence. PLoS One 2008;3:e0002051 doi:10.1371/journal.pone.0002051 pmid:18446219

    CrossRefPubMed
21. 21.↵
    1. Staffen W,
    2. Mair A,
    3. Zauner H, et al

    . Cognitive function and fMRI in patients with multiple sclerosis: evidence for compensatory cortical activation during an attention task. Brain 2002;125:1275–82 doi:10.1093/brain/awf125 pmid:12023316

    CrossRefPubMedWeb of Science
22. 22.↵
    1. Hogan AM,
    2. Vargha-Khadem F,
    3. Saunders DE, et al

    . Impact of frontal white matter lesions on performance monitoring: ERP evidence for cortical disconnection. Brain 2006;129:2177–88 doi:10.1093/brain/awl160 pmid:16815874

    CrossRefPubMedWeb of Science
23. 23.↵
    1. Dicks E,
    2. Tijms BM,
    3. Ten Kate M, et al

    . Gray matter network measures are associated with cognitive decline in mild cognitive impairment. Neurobiol Aging 2018;61:198–206 doi:10.1016/j.neurobiolaging.2017.09.029 pmid:29111486

    CrossRefPubMed
24. 24.↵
    1. Tijms BM,
    2. Moller C,
    3. Vrenken H, et al

    . Single-subject grey matter graphs in Alzheimer’s disease. PLoS One 2013;8:e58921 doi:10.1371/journal.pone.0058921 pmid:23536835

    CrossRefPubMed
25. 25.↵
    1. Prins ND,
    2. van Dijk EJ,
    3. den Heijer T, et al

    . Cerebral small-vessel disease and decline in information processing speed, executive function and memory. Brain 2005;128:2034–41 doi:10.1093/brain/awh553 pmid:15947059

    CrossRefPubMedWeb of Science
26. 26.↵
    1. Ylikoski R,
    2. Ylikoski A,
    3. Erkinjuntti T, et al

    . White matter changes in healthy elderly persons correlate with attention and speed of mental processing. Arch Neurol 1993;50:818–24 doi:10.1001/archneur.1993.00540080029009 pmid:8352667

    CrossRefPubMedWeb of Science
27. 27.↵
    1. He Y,
    2. Dagher A,
    3. Chen Z, et al

    . Impaired small-world efficiency in structural cortical networks in multiple sclerosis associated with white matter lesion load. Brain 2009;132:3366–79 doi:10.1093/brain/awp089 pmid:19439423

    CrossRefPubMedWeb of Science
28. 28.↵
    1. Gamboa OL,
    2. Tagliazucchi E,
    3. von Wegner F, et al

    . Working memory performance of early patients with MS correlates inversely with modularity increases in resting state functional connectivity networks. Neuroimage 2014;94:385–95 doi:10.1016/j.neuroimage.2013.12.008 pmid:24361662

    CrossRefPubMedWeb of Science
29. 29.↵
    1. Louapre C,
    2. Perlbarg V,
    3. Garcia-Lorenzo D, et al

    . Brain networks disconnection in early multiple sclerosis cognitive deficits: an anatomofunctional study. Hum Brain Mapp 2014;35:4706–17 doi:10.1002/hbm.22505 pmid:24687771

    CrossRefPubMed
30. 30.↵
    1. Lo CY,
    2. Wang PN,
    3. Chou KH, et al

    . Diffusion tensor tractography reveals abnormal topological organization in structural cortical networks in Alzheimer’s disease. J Neurosci 2010;30:16876–85 doi:10.1523/JNEUROSCI.4136-10.2010 pmid:21159959

    Abstract/FREE Full Text
31. 31.↵
    1. Tijms BM,
    2. Wink AM,
    3. de Haan W, et al

    . Alzheimer’s disease: connecting findings from graph theoretical studies of brain networks. Neurobiol Aging 2013;34:2023–36 doi:10.1016/j.neurobiolaging.2013.02.020 pmid:23541878

    CrossRefPubMedWeb of Science